Koninklijke Financial Statements From 2010 to 2025

PHG Stock  USD 26.62  0.39  1.44%   
Koninklijke Philips' financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing Koninklijke Philips' valuation are provided below:
Koninklijke Philips NV does not presently have any fundamental ratios for analysis.
Check Koninklijke Philips financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Koninklijke Philips' main balance sheet or income statement drivers, such as , as well as many indicators such as . Koninklijke financial statements analysis is a perfect complement when working with Koninklijke Philips Valuation or Volatility modules.
Check out the analysis of Koninklijke Philips Correlation against competitors.

Koninklijke Philips NV Company Return On Equity Analysis

Koninklijke Philips' Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.

Return On Equity

 = 

Net Income

Total Equity

More About Return On Equity | All Equity Analysis

Current Koninklijke Philips Return On Equity

    
  0.0154  
Most of Koninklijke Philips' fundamental indicators, such as Return On Equity, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Koninklijke Philips NV is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.
Competition

Based on the latest financial disclosure, Koninklijke Philips NV has a Return On Equity of 0.0154. This is 100.06% lower than that of the Health Care Equipment & Supplies sector and 100.18% lower than that of the Health Care industry. The return on equity for all United States stocks is 104.97% lower than that of the firm.

Koninklijke Philips Fundamental Drivers Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Koninklijke Philips's current stock value. Our valuation model uses many indicators to compare Koninklijke Philips value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Koninklijke Philips competition to find correlations between indicators driving Koninklijke Philips's intrinsic value. More Info.
Koninklijke Philips NV is rated below average in return on equity category among its peers. It also is rated below average in return on asset category among its peers reporting about  1.54  of Return On Asset per Return On Equity. Comparative valuation analysis is a catch-all technique that is used if you cannot value Koninklijke Philips by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.

About Koninklijke Philips Financial Statements

Koninklijke Philips stakeholders use historical fundamental indicators, such as Koninklijke Philips' revenue or net income, to determine how well the company is positioned to perform in the future. Although Koninklijke Philips investors may analyze each financial statement separately, they are all interrelated. For example, changes in Koninklijke Philips' assets and liabilities are reflected in the revenues and expenses on Koninklijke Philips' income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Koninklijke Philips NV. Please read more on our technical analysis and fundamental analysis pages.
Koninklijke Philips N.V. operates as a health technology company in North America and internationally. Koninklijke Philips N.V. was founded in 1891 and is headquartered in Amsterdam, the Netherlands. Koninklijke Philips operates under Medical Devices classification in the United States and is traded on New York Stock Exchange. It employs 79097 people.

Currently Active Assets on Macroaxis

When determining whether Koninklijke Philips is a strong investment it is important to analyze Koninklijke Philips' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Koninklijke Philips' future performance. For an informed investment choice regarding Koninklijke Stock, refer to the following important reports:
Check out the analysis of Koninklijke Philips Correlation against competitors.
You can also try the Bond Analysis module to evaluate and analyze corporate bonds as a potential investment for your portfolios..
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Koninklijke Philips. If investors know Koninklijke will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Koninklijke Philips listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Koninklijke Philips is measured differently than its book value, which is the value of Koninklijke that is recorded on the company's balance sheet. Investors also form their own opinion of Koninklijke Philips' value that differs from its market value or its book value, called intrinsic value, which is Koninklijke Philips' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Koninklijke Philips' market value can be influenced by many factors that don't directly affect Koninklijke Philips' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Koninklijke Philips' value and its price as these two are different measures arrived at by different means. Investors typically determine if Koninklijke Philips is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Koninklijke Philips' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.